Artificial Organs-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Artificial Organs-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Artificial Organs industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Artificial Organs 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Artificial Organs worldwide and market share by regions, with company and product introduction, position in the Artificial Organs market
Market status and development trend of Artificial Organs by types and applications
Cost and profit status of Artificial Organs, and marketing status
Market growth drivers and challenges
The report segments the global Artificial Organs market as:
Global Artificial Organs Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Artificial Organs Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Artificial Heart
Artificial Liver
Artificial Pancreas
Artificial Lungs
Artificial Kidney
Other
Global Artificial Organs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Clinic
Other
Global Artificial Organs Market: Manufacturers Segment Analysis (Company and Product introduction, Artificial Organs Sales Volume, Revenue, Price and Gross Margin):
Abbott Diabetes Care, Inc.
Abiomed, Inc.
Asahi Kasei Medical Co., Ltd.
Baxter International, Inc.
F.Hoffmann-La Roche Ltd.
Fresenius Medical Care AG & Co. KGaA
HeartWare International, Inc.
Jarvik Heart, Inc.
Medtronic, Inc.
Nikkiso Co., Ltd.
Nipro Corporation
SynCardia Systems, Inc.
Terumo Heart, Inc.
Thoratec Corp.
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Artificial Organs-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Artificial Organs industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Artificial Organs 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Artificial Organs worldwide and market share by regions, with company and product introduction, position in the Artificial Organs market
Market status and development trend of Artificial Organs by types and applications
Cost and profit status of Artificial Organs, and marketing status
Market growth drivers and challenges
The report segments the global Artificial Organs market as:
Global Artificial Organs Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Artificial Organs Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Artificial Heart
Artificial Liver
Artificial Pancreas
Artificial Lungs
Artificial Kidney
Other
Global Artificial Organs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Clinic
Other
Global Artificial Organs Market: Manufacturers Segment Analysis (Company and Product introduction, Artificial Organs Sales Volume, Revenue, Price and Gross Margin):
Abbott Diabetes Care, Inc.
Abiomed, Inc.
Asahi Kasei Medical Co., Ltd.
Baxter International, Inc.
F.Hoffmann-La Roche Ltd.
Fresenius Medical Care AG & Co. KGaA
HeartWare International, Inc.
Jarvik Heart, Inc.
Medtronic, Inc.
Nikkiso Co., Ltd.
Nipro Corporation
SynCardia Systems, Inc.
Terumo Heart, Inc.
Thoratec Corp.
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ARTIFICIAL ORGANS
1.1 Definition of Artificial Organs in This Report
1.2 Commercial Types of Artificial Organs
1.2.1 Artificial Heart
1.2.2 Artificial Liver
1.2.3 Artificial Pancreas
1.2.4 Artificial Lungs
1.2.5 Artificial Kidney
1.2.6 Other
1.3 Downstream Application of Artificial Organs
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Other
1.4 Development History of Artificial Organs
1.5 Market Status and Trend of Artificial Organs 2013-2023
1.5.1 Global Artificial Organs Market Status and Trend 2013-2023
1.5.2 Regional Artificial Organs Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Artificial Organs 2013-2017
2.2 Sales Market of Artificial Organs by Regions
2.2.1 Sales Volume of Artificial Organs by Regions
2.2.2 Sales Value of Artificial Organs by Regions
2.3 Production Market of Artificial Organs by Regions
2.4 Global Market Forecast of Artificial Organs 2018-2023
2.4.1 Global Market Forecast of Artificial Organs 2018-2023
2.4.2 Market Forecast of Artificial Organs by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Artificial Organs by Types
3.2 Sales Value of Artificial Organs by Types
3.3 Market Forecast of Artificial Organs by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Artificial Organs by Downstream Industry
4.2 Global Market Forecast of Artificial Organs by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Artificial Organs Market Status by Countries
5.1.1 North America Artificial Organs Sales by Countries (2013-2017)
5.1.2 North America Artificial Organs Revenue by Countries (2013-2017)
5.1.3 United States Artificial Organs Market Status (2013-2017)
5.1.4 Canada Artificial Organs Market Status (2013-2017)
5.1.5 Mexico Artificial Organs Market Status (2013-2017)
5.2 North America Artificial Organs Market Status by Manufacturers
5.3 North America Artificial Organs Market Status by Type (2013-2017)
5.3.1 North America Artificial Organs Sales by Type (2013-2017)
5.3.2 North America Artificial Organs Revenue by Type (2013-2017)
5.4 North America Artificial Organs Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Artificial Organs Market Status by Countries
6.1.1 Europe Artificial Organs Sales by Countries (2013-2017)
6.1.2 Europe Artificial Organs Revenue by Countries (2013-2017)
6.1.3 Germany Artificial Organs Market Status (2013-2017)
6.1.4 UK Artificial Organs Market Status (2013-2017)
6.1.5 France Artificial Organs Market Status (2013-2017)
6.1.6 Italy Artificial Organs Market Status (2013-2017)
6.1.7 Russia Artificial Organs Market Status (2013-2017)
6.1.8 Spain Artificial Organs Market Status (2013-2017)
6.1.9 Benelux Artificial Organs Market Status (2013-2017)
6.2 Europe Artificial Organs Market Status by Manufacturers
6.3 Europe Artificial Organs Market Status by Type (2013-2017)
6.3.1 Europe Artificial Organs Sales by Type (2013-2017)
6.3.2 Europe Artificial Organs Revenue by Type (2013-2017)
6.4 Europe Artificial Organs Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Artificial Organs Market Status by Countries
7.1.1 Asia Pacific Artificial Organs Sales by Countries (2013-2017)
7.1.2 Asia Pacific Artificial Organs Revenue by Countries (2013-2017)
7.1.3 China Artificial Organs Market Status (2013-2017)
7.1.4 Japan Artificial Organs Market Status (2013-2017)
7.1.5 India Artificial Organs Market Status (2013-2017)
7.1.6 Southeast Asia Artificial Organs Market Status (2013-2017)
7.1.7 Australia Artificial Organs Market Status (2013-2017)
7.2 Asia Pacific Artificial Organs Market Status by Manufacturers
7.3 Asia Pacific Artificial Organs Market Status by Type (2013-2017)
7.3.1 Asia Pacific Artificial Organs Sales by Type (2013-2017)
7.3.2 Asia Pacific Artificial Organs Revenue by Type (2013-2017)
7.4 Asia Pacific Artificial Organs Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Artificial Organs Market Status by Countries
8.1.1 Latin America Artificial Organs Sales by Countries (2013-2017)
8.1.2 Latin America Artificial Organs Revenue by Countries (2013-2017)
8.1.3 Brazil Artificial Organs Market Status (2013-2017)
8.1.4 Argentina Artificial Organs Market Status (2013-2017)
8.1.5 Colombia Artificial Organs Market Status (2013-2017)
8.2 Latin America Artificial Organs Market Status by Manufacturers
8.3 Latin America Artificial Organs Market Status by Type (2013-2017)
8.3.1 Latin America Artificial Organs Sales by Type (2013-2017)
8.3.2 Latin America Artificial Organs Revenue by Type (2013-2017)
8.4 Latin America Artificial Organs Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Artificial Organs Market Status by Countries
9.1.1 Middle East and Africa Artificial Organs Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Artificial Organs Revenue by Countries (2013-2017)
9.1.3 Middle East Artificial Organs Market Status (2013-2017)
9.1.4 Africa Artificial Organs Market Status (2013-2017)
9.2 Middle East and Africa Artificial Organs Market Status by Manufacturers
9.3 Middle East and Africa Artificial Organs Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Artificial Organs Sales by Type (2013-2017)
9.3.2 Middle East and Africa Artificial Organs Revenue by Type (2013-2017)
9.4 Middle East and Africa Artificial Organs Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF ARTIFICIAL ORGANS
10.1 Global Economy Situation and Trend Overview
10.2 Artificial Organs Downstream Industry Situation and Trend Overview
CHAPTER 11 ARTIFICIAL ORGANS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Artificial Organs by Major Manufacturers
11.2 Production Value of Artificial Organs by Major Manufacturers
11.3 Basic Information of Artificial Organs by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Artificial Organs Major Manufacturer
11.3.2 Employees and Revenue Level of Artificial Organs Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 ARTIFICIAL ORGANS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Abbott Diabetes Care, Inc.
12.1.1 Company profile
12.1.2 Representative Artificial Organs Product
12.1.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Abbott Diabetes Care, Inc.
12.2 Abiomed, Inc.
12.2.1 Company profile
12.2.2 Representative Artificial Organs Product
12.2.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Abiomed, Inc.
12.3 Asahi Kasei Medical Co., Ltd.
12.3.1 Company profile
12.3.2 Representative Artificial Organs Product
12.3.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Asahi Kasei Medical Co., Ltd.
12.4 Baxter International, Inc.
12.4.1 Company profile
12.4.2 Representative Artificial Organs Product
12.4.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Baxter International, Inc.
12.5 F.Hoffmann-La Roche Ltd.
12.5.1 Company profile
12.5.2 Representative Artificial Organs Product
12.5.3 Artificial Organs Sales, Revenue, Price and Gross Margin of F.Hoffmann-La Roche Ltd.
12.6 Fresenius Medical Care AG & Co. KGaA
12.6.1 Company profile
12.6.2 Representative Artificial Organs Product
12.6.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Fresenius Medical Care AG & Co. KGaA
12.7 HeartWare International, Inc.
12.7.1 Company profile
12.7.2 Representative Artificial Organs Product
12.7.3 Artificial Organs Sales, Revenue, Price and Gross Margin of HeartWare International, Inc.
12.8 Jarvik Heart, Inc.
12.8.1 Company profile
12.8.2 Representative Artificial Organs Product
12.8.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Jarvik Heart, Inc.
12.9 Medtronic, Inc.
12.9.1 Company profile
12.9.2 Representative Artificial Organs Product
12.9.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Medtronic, Inc.
12.10 Nikkiso Co., Ltd.
12.10.1 Company profile
12.10.2 Representative Artificial Organs Product
12.10.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Nikkiso Co., Ltd.
12.11 Nipro Corporation
12.11.1 Company profile
12.11.2 Representative Artificial Organs Product
12.11.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Nipro Corporation
12.12 SynCardia Systems, Inc.
12.12.1 Company profile
12.12.2 Representative Artificial Organs Product
12.12.3 Artificial Organs Sales, Revenue, Price and Gross Margin of SynCardia Systems, Inc.
12.13 Terumo Heart, Inc.
12.13.1 Company profile
12.13.2 Representative Artificial Organs Product
12.13.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Terumo Heart, Inc.
12.14 Thoratec Corp.
12.14.1 Company profile
12.14.2 Representative Artificial Organs Product
12.14.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Thoratec Corp.
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ARTIFICIAL ORGANS
13.1 Industry Chain of Artificial Organs
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF ARTIFICIAL ORGANS
14.1 Cost Structure Analysis of Artificial Organs
14.2 Raw Materials Cost Analysis of Artificial Organs
14.3 Labor Cost Analysis of Artificial Organs
14.4 Manufacturing Expenses Analysis of Artificial Organs
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Artificial Organs in This Report
1.2 Commercial Types of Artificial Organs
1.2.1 Artificial Heart
1.2.2 Artificial Liver
1.2.3 Artificial Pancreas
1.2.4 Artificial Lungs
1.2.5 Artificial Kidney
1.2.6 Other
1.3 Downstream Application of Artificial Organs
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Other
1.4 Development History of Artificial Organs
1.5 Market Status and Trend of Artificial Organs 2013-2023
1.5.1 Global Artificial Organs Market Status and Trend 2013-2023
1.5.2 Regional Artificial Organs Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Artificial Organs 2013-2017
2.2 Sales Market of Artificial Organs by Regions
2.2.1 Sales Volume of Artificial Organs by Regions
2.2.2 Sales Value of Artificial Organs by Regions
2.3 Production Market of Artificial Organs by Regions
2.4 Global Market Forecast of Artificial Organs 2018-2023
2.4.1 Global Market Forecast of Artificial Organs 2018-2023
2.4.2 Market Forecast of Artificial Organs by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Artificial Organs by Types
3.2 Sales Value of Artificial Organs by Types
3.3 Market Forecast of Artificial Organs by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Artificial Organs by Downstream Industry
4.2 Global Market Forecast of Artificial Organs by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Artificial Organs Market Status by Countries
5.1.1 North America Artificial Organs Sales by Countries (2013-2017)
5.1.2 North America Artificial Organs Revenue by Countries (2013-2017)
5.1.3 United States Artificial Organs Market Status (2013-2017)
5.1.4 Canada Artificial Organs Market Status (2013-2017)
5.1.5 Mexico Artificial Organs Market Status (2013-2017)
5.2 North America Artificial Organs Market Status by Manufacturers
5.3 North America Artificial Organs Market Status by Type (2013-2017)
5.3.1 North America Artificial Organs Sales by Type (2013-2017)
5.3.2 North America Artificial Organs Revenue by Type (2013-2017)
5.4 North America Artificial Organs Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Artificial Organs Market Status by Countries
6.1.1 Europe Artificial Organs Sales by Countries (2013-2017)
6.1.2 Europe Artificial Organs Revenue by Countries (2013-2017)
6.1.3 Germany Artificial Organs Market Status (2013-2017)
6.1.4 UK Artificial Organs Market Status (2013-2017)
6.1.5 France Artificial Organs Market Status (2013-2017)
6.1.6 Italy Artificial Organs Market Status (2013-2017)
6.1.7 Russia Artificial Organs Market Status (2013-2017)
6.1.8 Spain Artificial Organs Market Status (2013-2017)
6.1.9 Benelux Artificial Organs Market Status (2013-2017)
6.2 Europe Artificial Organs Market Status by Manufacturers
6.3 Europe Artificial Organs Market Status by Type (2013-2017)
6.3.1 Europe Artificial Organs Sales by Type (2013-2017)
6.3.2 Europe Artificial Organs Revenue by Type (2013-2017)
6.4 Europe Artificial Organs Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Artificial Organs Market Status by Countries
7.1.1 Asia Pacific Artificial Organs Sales by Countries (2013-2017)
7.1.2 Asia Pacific Artificial Organs Revenue by Countries (2013-2017)
7.1.3 China Artificial Organs Market Status (2013-2017)
7.1.4 Japan Artificial Organs Market Status (2013-2017)
7.1.5 India Artificial Organs Market Status (2013-2017)
7.1.6 Southeast Asia Artificial Organs Market Status (2013-2017)
7.1.7 Australia Artificial Organs Market Status (2013-2017)
7.2 Asia Pacific Artificial Organs Market Status by Manufacturers
7.3 Asia Pacific Artificial Organs Market Status by Type (2013-2017)
7.3.1 Asia Pacific Artificial Organs Sales by Type (2013-2017)
7.3.2 Asia Pacific Artificial Organs Revenue by Type (2013-2017)
7.4 Asia Pacific Artificial Organs Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Artificial Organs Market Status by Countries
8.1.1 Latin America Artificial Organs Sales by Countries (2013-2017)
8.1.2 Latin America Artificial Organs Revenue by Countries (2013-2017)
8.1.3 Brazil Artificial Organs Market Status (2013-2017)
8.1.4 Argentina Artificial Organs Market Status (2013-2017)
8.1.5 Colombia Artificial Organs Market Status (2013-2017)
8.2 Latin America Artificial Organs Market Status by Manufacturers
8.3 Latin America Artificial Organs Market Status by Type (2013-2017)
8.3.1 Latin America Artificial Organs Sales by Type (2013-2017)
8.3.2 Latin America Artificial Organs Revenue by Type (2013-2017)
8.4 Latin America Artificial Organs Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Artificial Organs Market Status by Countries
9.1.1 Middle East and Africa Artificial Organs Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Artificial Organs Revenue by Countries (2013-2017)
9.1.3 Middle East Artificial Organs Market Status (2013-2017)
9.1.4 Africa Artificial Organs Market Status (2013-2017)
9.2 Middle East and Africa Artificial Organs Market Status by Manufacturers
9.3 Middle East and Africa Artificial Organs Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Artificial Organs Sales by Type (2013-2017)
9.3.2 Middle East and Africa Artificial Organs Revenue by Type (2013-2017)
9.4 Middle East and Africa Artificial Organs Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF ARTIFICIAL ORGANS
10.1 Global Economy Situation and Trend Overview
10.2 Artificial Organs Downstream Industry Situation and Trend Overview
CHAPTER 11 ARTIFICIAL ORGANS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Artificial Organs by Major Manufacturers
11.2 Production Value of Artificial Organs by Major Manufacturers
11.3 Basic Information of Artificial Organs by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Artificial Organs Major Manufacturer
11.3.2 Employees and Revenue Level of Artificial Organs Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 ARTIFICIAL ORGANS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Abbott Diabetes Care, Inc.
12.1.1 Company profile
12.1.2 Representative Artificial Organs Product
12.1.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Abbott Diabetes Care, Inc.
12.2 Abiomed, Inc.
12.2.1 Company profile
12.2.2 Representative Artificial Organs Product
12.2.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Abiomed, Inc.
12.3 Asahi Kasei Medical Co., Ltd.
12.3.1 Company profile
12.3.2 Representative Artificial Organs Product
12.3.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Asahi Kasei Medical Co., Ltd.
12.4 Baxter International, Inc.
12.4.1 Company profile
12.4.2 Representative Artificial Organs Product
12.4.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Baxter International, Inc.
12.5 F.Hoffmann-La Roche Ltd.
12.5.1 Company profile
12.5.2 Representative Artificial Organs Product
12.5.3 Artificial Organs Sales, Revenue, Price and Gross Margin of F.Hoffmann-La Roche Ltd.
12.6 Fresenius Medical Care AG & Co. KGaA
12.6.1 Company profile
12.6.2 Representative Artificial Organs Product
12.6.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Fresenius Medical Care AG & Co. KGaA
12.7 HeartWare International, Inc.
12.7.1 Company profile
12.7.2 Representative Artificial Organs Product
12.7.3 Artificial Organs Sales, Revenue, Price and Gross Margin of HeartWare International, Inc.
12.8 Jarvik Heart, Inc.
12.8.1 Company profile
12.8.2 Representative Artificial Organs Product
12.8.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Jarvik Heart, Inc.
12.9 Medtronic, Inc.
12.9.1 Company profile
12.9.2 Representative Artificial Organs Product
12.9.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Medtronic, Inc.
12.10 Nikkiso Co., Ltd.
12.10.1 Company profile
12.10.2 Representative Artificial Organs Product
12.10.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Nikkiso Co., Ltd.
12.11 Nipro Corporation
12.11.1 Company profile
12.11.2 Representative Artificial Organs Product
12.11.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Nipro Corporation
12.12 SynCardia Systems, Inc.
12.12.1 Company profile
12.12.2 Representative Artificial Organs Product
12.12.3 Artificial Organs Sales, Revenue, Price and Gross Margin of SynCardia Systems, Inc.
12.13 Terumo Heart, Inc.
12.13.1 Company profile
12.13.2 Representative Artificial Organs Product
12.13.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Terumo Heart, Inc.
12.14 Thoratec Corp.
12.14.1 Company profile
12.14.2 Representative Artificial Organs Product
12.14.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Thoratec Corp.
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ARTIFICIAL ORGANS
13.1 Industry Chain of Artificial Organs
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF ARTIFICIAL ORGANS
14.1 Cost Structure Analysis of Artificial Organs
14.2 Raw Materials Cost Analysis of Artificial Organs
14.3 Labor Cost Analysis of Artificial Organs
14.4 Manufacturing Expenses Analysis of Artificial Organs
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
